Related references
Note: Only part of the references are listed.Association between gestational PFAS exposure and Children's adiposity in a diverse population
Michael S. Bloom et al.
ENVIRONMENTAL RESEARCH (2022)
Gestational perfluoroalkyl substance exposure and body mass index trajectories over the first 12 years of life
Joseph M. Braun et al.
INTERNATIONAL JOURNAL OF OBESITY (2021)
Obesity and endocrine-disrupting chemicals
Angelica Amorim Amato et al.
ENDOCRINE CONNECTIONS (2021)
Regulating PFAS as a Chemical Class under the California Safer Consumer Products Program
Simona Andreea Balan et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2021)
Perfluoroalkyl Acid Binding with Peroxisome Proliferator-Activated Receptors α, γ, and δ, and Fatty Acid Binding Proteins by Equilibrium Dialysis with a Comparison of Methods
Manoochehr Khazaee et al.
TOXICS (2021)
PFAS exposure and overweight/obesity among children in a nationally representative sample
Sarah Dee Geiger et al.
CHEMOSPHERE (2021)
Perfluoroalkyl Chemicals and Male Reproductive Health: Do PFOA and PFOS Increase Risk for Male Infertility?
Pheruza Tarapore et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)
Associations of perfluoroalkyl and polyfluoroalkyl substances (PFAS) and PFAS mixtures with adipokines in midlife women
Ning Ding et al.
INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH (2021)
Leveraging Nuclear Receptors as Targets for Pathological Ocular Vascular Diseases
Pei-Li Yao et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Serum concentrations of perfluoroalkyl substances and their association with osteoporosis in a population in Jeddah, Saudi Arabia
Abeer A. Banjabi et al.
ENVIRONMENTAL RESEARCH (2020)
Peroxisome proliferator-activated receptor gamma expression along the male genital system and its role in male fertility
Marta Santoro et al.
HUMAN REPRODUCTION (2020)
Exposure to Per- and Polyfluoroalkyl Substances and Adiposity at Age 12 Years: Evaluating Periods of Susceptibility
Yun Liu et al.
ENVIRONMENTAL SCIENCE & TECHNOLOGY (2020)
Transcriptional Factors of Thermogenic Adipocyte Development and Generation of Brown and Beige Adipocytes From Stem Cells
Thi-Tuong Van Nguyen et al.
STEM CELL REVIEWS AND REPORTS (2020)
Marrow adiposity and bone: Review of clinical implications
Julien Paccou et al.
BONE (2019)
Renal function and isomers of perfluorooctanoate (PFOA) and perfluorooctanesulfonate (PFOS): Isomers of C8 Health Project in China
Jia Wang et al.
CHEMOSPHERE (2019)
Environmental and human relevant PFOS and PFOA doses alter human mesenchymal stem cell self-renewal, adipogenesis and osteogenesis
Shuyu Liu et al.
ECOTOXICOLOGY AND ENVIRONMENTAL SAFETY (2019)
Adipogenic Activity of Oligomeric Hexafluoropropylene Oxide (Perfluorooctanoic Acid Alternative) through Peroxisome Proliferator-Activated Receptor γ Pathway
Chuan-Hai Li et al.
ENVIRONMENTAL SCIENCE & TECHNOLOGY (2019)
Chronic kidney disease is associated with low BMD at the hip but not at the spine
K. S. Bezerra de Carvalho et al.
OSTEOPOROSIS INTERNATIONAL (2019)
Contamination of groundwater with per- and polyfluoroalkyl substances (PFAS) from legacy landfills in an urban re-development precinct
Emily Hepburn et al.
ENVIRONMENTAL POLLUTION (2019)
Maternal exposure causes mitochondrial dysfunction in brain, liver, and heart of mouse fetus: An explanation for perfluorooctanoic acid induced abortion and developmental toxicity
Ahmad Salimi et al.
ENVIRONMENTAL TOXICOLOGY (2019)
Tap Water Contributions to Plasma Concentrations of Poly- and Perfluoroalkyl Substances (PFAS) in a Nationwide Prospective Cohort of US Women
Xindi C. Hu et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2019)
Multitarget PPARγ agonists as innovative modulators of the metabolic syndrome
Alessandra Ammazzalorso et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Per- and Polyfluoroalkyl Substance Plasma Concentrations and Bone Mineral Density in Midchildhood: A Cross-Sectional Study (Project Viva, United States)
Rachel Cluett et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2019)
Bone metabolism, bone mineral density and low-energy fractures 10 years after Roux-en-Y gastric bypass
Ingvild Kristine Blom-Hogestol et al.
BONE (2019)
A role of peroxisome proliferator-activated receptor γ in non-alcoholic fatty liver disease
Josephine Skat-Rordam et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2019)
Environmental perfluoroalkyl acid exposures are associated with liver disease characterized by apoptosis and altered serum adipocytokines
John Bassler et al.
ENVIRONMENTAL POLLUTION (2019)
Per and polyfluoroalkyl substances (PFAS) blood levels after contamination of a community water supply and comparison with 2013-2014 NHANES
Judith M. Graber et al.
JOURNAL OF EXPOSURE SCIENCE AND ENVIRONMENTAL EPIDEMIOLOGY (2019)
The prevention of tracheal graft occlusion using pioglitazone: A mouse tracheal transplant model study
Takao Shigenobu et al.
TRANSPLANT IMMUNOLOGY (2019)
Dua PPARα/γ activation inhibits SIRT1-PGC1α axis and causes cardiac dysfunction
Charikleia Kalliora et al.
JCI INSIGHT (2019)
Effects of perfluorooctanoic acid exposure during pregnancy on the reproduction and development of male offspring mice
Pengyan Song et al.
ANDROLOGIA (2018)
Prenatal exposure to persistent organic pollutants and child overweight/obesity at 5-year follow- up: a prospective cohort study
Hilde B. Lauritzen et al.
ENVIRONMENTAL HEALTH (2018)
Role of the Nrf2-ARE pathway in perfluorooctanoic acid (PFOA)-induced hepatotoxicity in Rana nigromaculata
Juan Tang et al.
ENVIRONMENTAL POLLUTION (2018)
Evaluation of a national data set for insights into sources, composition, and concentrations of per- and polyfluoroalkyl substances (PFASs) in US drinking water
Jennifer L. Guelfo et al.
ENVIRONMENTAL POLLUTION (2018)
Insights into the Role of PPARβ/δ in NAFLD
Jiapeng Chen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Maintenance of Kidney Metabolic Homeostasis by PPAR Gamma
Patricia Corrales et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Immunotoxic and hepatotoxic effects of perfluoro-n-decanoic acid (PFDA) on female Harlan Sprague-Dawley rats and B6C3F1/N mice when administered by oral gavage for 28 days
Rachel P. Frawley et al.
JOURNAL OF IMMUNOTOXICOLOGY (2018)
PPAR-gamma in innate and adaptive lung immunity
Samuel Philip Nobs et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2018)
Affinity-based separation methods for the study of biological interactions: The case of peroxisome proliferator-activated receptors in drug discovery
Caterina Temporini et al.
METHODS (2018)
Harvesting the promise of AOPs: An assessment and recommendations
Annamaria Carusi et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2018)
PPAR-gamma and Wnt Regulate the Differentiation of MSCs into Adipocytes and Osteoblasts Respectively
Yue Li et al.
CURRENT STEM CELL RESEARCH & THERAPY (2018)
Perfluoroalkyl substances and changes in body weight and resting metabolic rate in response to weight-loss diets: A prospective study
Gang Liu et al.
PLOS MEDICINE (2018)
Bone Marrow Adipose Tissue and Skeletal Health
Shanmugam Muruganandan et al.
CURRENT OSTEOPOROSIS REPORTS (2018)
Sulfluramid use in Brazilian agriculture: A source of per- and polyfluoroalkyl substances (PFASs) to the environment
Rodrigo A. Nascimento et al.
ENVIRONMENTAL POLLUTION (2018)
Crosstalk between PPARγ Ligands and Inflammatory-Related Pathways in Natural T-Regulatory Cells from Type 1 Diabetes Mouse Model
S. Zulkafli Nor Effa et al.
BIOMOLECULES (2018)
Perfluoroalkyl acids in aqueous samples from Germany and Kenya
Umer Shafique et al.
ENVIRONMENTAL SCIENCE AND POLLUTION RESEARCH (2017)
PPAR-, a lipid-sensing transcription factor, regulates blood-brain barrier efflux transporter expression
Vijay R. More et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2017)
Retinoid X Receptor Activation Alters the Chromatin Landscape To Commit Mesenchymal Stem Cells to the Adipose Lineage
Bassem M. Shoucri et al.
ENDOCRINOLOGY (2017)
Reduced kidney function is associated with BMD, bone loss and markers of mineral homeostasis in older women: a 10-year longitudinal study
L. Malmgren et al.
OSTEOPOROSIS INTERNATIONAL (2017)
Impact of pioglitazone on bone mineral density and bone marrow fat content
L. M. Pop et al.
OSTEOPOROSIS INTERNATIONAL (2017)
Poly- and perfluorinated compounds activate human pregnane X receptor
Yi-Ming Zhang et al.
TOXICOLOGY (2017)
PPARα-independent transcriptional targets of perfluoroalkyl acids revealed by transcript profiling
Mitchell B. Rosen et al.
TOXICOLOGY (2017)
Emerging poly- and perfluoroalkyl substances in the aquatic environment: A review of current literature
Feng Xiao
WATER RESEARCH (2017)
Interaction between peroxisome proliferator-activated receptor gamma polymorphism and obesity on type 2 diabetes in a Chinese Han population
Xiaohui Lv et al.
DIABETOLOGY & METABOLIC SYNDROME (2017)
The CompTox Chemistry Dashboard: a community data resource for environmental chemistry
Antony J. Williams et al.
JOURNAL OF CHEMINFORMATICS (2017)
Association of Perfluoroalkyl Substances, Bone Mineral Density, and Osteoporosis in the US Population in NHANES 2009-2010
Naila Khalil et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2016)
Maternal serum perfluoroalkyl substances during pregnancy and duration of breastfeeding
Megan E. Romano et al.
ENVIRONMENTAL RESEARCH (2016)
PPARγ as a therapeutic target to rescue mitochondrial function in neurological disease
Juan Carlos Corona et al.
FREE RADICAL BIOLOGY AND MEDICINE (2016)
STAT5B deficiency: Impacts on human growth and immunity
Vivian Hwa
GROWTH HORMONE & IGF RESEARCH (2016)
Brain STAT5 signaling and behavioral control
Isadora C. Furigo et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2016)
Generalized Concentration Addition Modeling Predicts Mixture Effects of Environmental PPARγ Agonists
James Watt et al.
TOXICOLOGICAL SCIENCES (2016)
Effects of developmental exposure to perfluorooctanoic acid (PFOA) on long bone morphology and bone cell differentiation
A. Koskela et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2016)
Fatty acid activated PPARγ promotes tumorigenicity of prostate cancer cells by up regulating VEGF via PPAR responsive elements of the promoter
Farzad S. Forootan et al.
ONCOTARGET (2016)
A role for Peroxisome Proliferator-Activated Receptor Beta in T cell development
Isabelle Mothe-Satney et al.
SCIENTIFIC REPORTS (2016)
Sex-Based Selectivity of PPARγ Regulation in Th1, Th2, and Th17 Differentiation
Hong-Jai Park et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Peroxisome proliferator-activated receptor gamma signaling in human sperm physiology
Li-Li Liu et al.
ASIAN JOURNAL OF ANDROLOGY (2015)
Activation of PPARγ2 by PPARγ1 through a functional PPRE in transdifferentiation of myoblasts to adipocytes induced by EPA
Hefeng Luo et al.
CELL CYCLE (2015)
Mesenchymal Cell Contributions to the Stem Cell Niche
Youmna Kfoury et al.
CELL STEM CELL (2015)
Occurrence of perfluoroalkyl acids in environmental waters in Vietnam
Hanh Thi Duong et al.
CHEMOSPHERE (2015)
Determination of fluorotelomer alcohols in selected consumer products and preliminary investigation of their fate in the indoor environment
Xiaoyu Liu et al.
CHEMOSPHERE (2015)
The effect of thiazolidinediones on bone mineral density and bone turnover: systematic review and meta-analysis
Emma O. Billington et al.
DIABETOLOGIA (2015)
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
A. C. Gore et al.
ENDOCRINE REVIEWS (2015)
Perfluoroalkyl acids in selected wastewater treatment plants and their discharge load within the Lake Victoria basin in Kenya
Florah Chirikona et al.
ENVIRONMENTAL MONITORING AND ASSESSMENT (2015)
Variation in PPARG Is Associated With Longitudinal Change in Insulin Resistance in Mexican Americans at Risk for Type 2 Diabetes
Mary Helen Black et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
The mammary gland is a sensitive pubertal target in CD-1 and C57Bl/6 mice following perinatal perfluorooctanoic acid (PFOA) exposure
Deirdre K. Tucker et al.
REPRODUCTIVE TOXICOLOGY (2015)
Structurally-diverse, PPARγ-activating environmental toxicants induce adipogenesis and suppress osteogenesis in bone marrow mesenchymal stromal cells
James Watt et al.
TOXICOLOGY (2015)
Modeled PFOA Exposure and Coronary Artery Disease, Hypertension, and High Cholesterol in Community and Worker Cohorts
Andrea Winquist et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2014)
Proteomic Analysis of Mouse Testis Reveals Perfluorooctanoic Acid-Induced Reproductive Dysfunction via Direct Disturbance of Testicular Steroidogenic Machinery
Hongxia Zhang et al.
JOURNAL OF PROTEOME RESEARCH (2014)
Accumulation of perfluoroalkyl substances in human tissues
Francisca Perez et al.
ENVIRONMENT INTERNATIONAL (2013)
Transgenerational Inheritance of Increased Fat Depot Size, Stem Cell Reprogramming, and Hepatic Steatosis Elicited by Prenatal Exposure to the Obesogen Tributyltin in Mice
Raquel Chamorro-Garcia et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2013)
Calcaneal Quantitative Ultrasound as a Determinant of Bone Health Status: What Properties of Bone Does It Reflect?
Kok-Yong Chin et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2013)
PPARγ signaling and metabolism: the good, the bad and the future
Maryam Ahmadian et al.
NATURE MEDICINE (2013)
Perfluorooctanoic Acid and Cardiovascular Disease in US Adults
Anoop Shankar et al.
ARCHIVES OF INTERNAL MEDICINE (2012)
Association of Cartilage-Specific Deletion of Peroxisome Proliferator-Activated Receptor γ with Abnormal Endochondral Ossification and Impaired Cartilage Growth and Development in a Murine Model
Roxana Monemdjou et al.
ARTHRITIS AND RHEUMATISM (2012)
Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs
H. M. Colhoun et al.
DIABETOLOGIA (2012)
Prenatal Exposure to Perfluorooctanoate and Risk of Overweight at 20 Years of Age: A Prospective Cohort Study
Thorhallur I. Halldorsson et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2012)
PPARs: Fatty acid sensors controlling metabolism
Lars la Cour Poulsen et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2012)
Peroxisome Proliferator-Activated Receptor γ Is a Target for Halogenated Analogs of Bisphenol A
Anne Riu et al.
ENVIRONMENTAL HEALTH PERSPECTIVES (2011)
The environmental obesogen tributyltin chloride acts via peroxisome proliferator activated receptor gamma to induce adipogenesis in murine 3T3-L1 preadipocytes
Xia Li et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2011)
Update on Medications With Adverse Skeletal Effects
Caroline J. Davidge Pitts et al.
MAYO CLINIC PROCEEDINGS (2011)
Polymorphisms of the peroxisome proliferator-activated receptor γ (PPARγ) gene are associated with osteoporosis
T. Harslof et al.
OSTEOPOROSIS INTERNATIONAL (2011)
Characterization of Novel Ligands of ERα, Erβ, and PPARγ: The Case of Halogenated Bisphenol A and Their Conjugated Metabolites
Anne Riu et al.
TOXICOLOGICAL SCIENCES (2011)
Multiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytes
J. A. Bjork et al.
TOXICOLOGY (2011)
The peroxisome proliferator-activated receptor (PPAR) alpha agonist fenofibrate maintains bone mass, while the PPAR gamma agonist pioglitazone exaggerates bone loss, in ovariectomized rats
Astrid K. Stunes et al.
BMC ENDOCRINE DISORDERS (2011)
ADVERSE OUTCOME PATHWAYS: A CONCEPTUAL FRAMEWORK TO SUPPORT ECOTOXICOLOGY RESEARCH AND RISK ASSESSMENT
Gerald T. Ankley et al.
ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY (2010)
Covalent Peroxisome Proliferator-activated Receptor γ Adduction by Nitro-fatty Acids SELECTIVE LIGAND ACTIVITY AND ANTI-DIABETIC SIGNALING ACTIONS
Francisco J. Schopfer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Statins enhance peroxisome proliferator-activated receptor γ coactivator-1α activity to regulate energy metabolism
Wenxian Wang et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2010)
Prenatal Exposure to the Environmental Obesogen Tributyltin Predisposes Multipotent Stem Cells to Become Adipocytes
Severine Kirchner et al.
MOLECULAR ENDOCRINOLOGY (2010)
Levels and trends of poly- and perfluorinated compounds in the arctic environment
Craig M. Butt et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2010)
A New Concept Underlying Stem Cell Lineage Skewing That Explains the Detrimental Effects of Thiazolidinediones on Bone
Claudia Bruedigam et al.
STEM CELLS (2010)
Generalized concentration addition: A method for examining mixtures containing partial agonists
Gregory J. Howard et al.
JOURNAL OF THEORETICAL BIOLOGY (2009)
Phenotypic dichotomy following developmental exposure to perfluorooctanoic acid (PFOA) in female CD-1 mice: Low doses induce elevated serum leptin and insulin, and overweight in mid-life
Erin P. Hines et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2009)
Review of the expression of peroxisome proliferator-activated receptors alpha (PPARα), beta (PPARβ), and gamma (PPARγ) in rodent and human development
Barbara D. Abbott
REPRODUCTIVE TOXICOLOGY (2009)
Fat and beyond: The diverse biology of PPAR gamma
Peter Tontonoz et al.
ANNUAL REVIEW OF BIOCHEMISTRY (2008)
Quantitative expression patterns of peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) protein in mice
Elizabeth E. Girroir et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Pioglitazone versus Rosiglitazone: Effects on Lipids, Lipoproteins, and Apolipoproteins in Head-to-Head Randomized Clinical Studies
Mark A. Deeg et al.
PPAR RESEARCH (2008)
PPAR-γ regulates osteoclastogenesis in mice
Yihong Wan et al.
NATURE MEDICINE (2007)
Interleukin-10 is upregulated by nanomolar rosiglitazone treatment of mature dendritic cells and human CD4+T cells
Paul W. Thompson et al.
CYTOKINE (2007)
Safety issues and prospects for future generations of PPAR modulators
Anne Rubenstrunk et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2007)
Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone
Oxana P. Lazarenko et al.
ENDOCRINOLOGY (2007)
Osteoblasts support B-lymphocyte commitment and differentiation from hematopoietic stem cells
Jiang Zhu et al.
BLOOD (2007)
Gestational PFOA exposure of mice is associated with altered mammary gland development in dams and female offspring
Sally S. White et al.
TOXICOLOGICAL SCIENCES (2007)
Activation of mouse and human peroxisome proliferator-activated receptors (alpha, beta/delta, gamma) by perfluorooctanoic acid and perfluorooctane sulfonate
Margy L. Takacs et al.
TOXICOLOGICAL SCIENCES (2007)
Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes - a meta-analysis
P. Vestergaard
OSTEOPOROSIS INTERNATIONAL (2007)
Stat5 in the mammary gland: Controlling normal development and cancer
Itamar Barash
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids:: A comparison of human, mouse, and rat peroxisome proliferator-activated receptor-α, -β, and -γ, liver X receptor-β, and retinoid X receptor-α
John P. Vanden Heuvel et al.
TOXICOLOGICAL SCIENCES (2006)
Environmental obesogens:: Organotins and endocrine disruption via nuclear receptor signaling
Felix Grun et al.
ENDOCRINOLOGY (2006)
Environmental perchlorate: Why it matters
Andrea B. Kirk
ANALYTICA CHIMICA ACTA (2006)
Effects of perfluorooctanoic acid exposure during pregnancy in the mouse
C Lau et al.
TOXICOLOGICAL SCIENCES (2006)
Mechanisms of disease: is osteoporosis the obesity of bone?
CJ Rosen et al.
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2006)
Association between peroxisome proliferator-activated receptor γ hapotypes and the metabolic syndrome in French men and women
A Meirhaeghe et al.
DIABETES (2005)
Organotin compounds promote adipocyte differentiation as agonists of the peroxisome proliferator-activated receptor γ/retinoid x receptor pathway
T Kanayama et al.
MOLECULAR PHARMACOLOGY (2005)
Rosiglitazone causes bone loss in mice by suppressing osteoblast differentiation and bone formation
AA Ali et al.
ENDOCRINOLOGY (2005)
PPARγ signaling exacerbates mammary gland tumor development
E Saez et al.
GENES & DEVELOPMENT (2004)
PPARγ insufficiency enhances osteogenesis through osteoblast formation from bone marrow progenitors
T Akune et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Simultaneous, bidirectional inhibitory crosstalk between PPAR and STAT5b
JM Shipley et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2004)
Binding analyses between human PPAR gamma-LBD and ligands - Surface plasmon resonance biosensor assay correlating with circular dichroic spectroscopy determination and molecular docking
CY Yu et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2004)
Down-regulation of STAT5b transcriptional activity by ligand-activated peroxisome proliferator-activated receptor (PPAR) α and PPARγ
JM Shipley et al.
MOLECULAR PHARMACOLOGY (2003)
Lipid metabolome-wide effects of the PPARγ agonist rosiglitazone
SM Watkins et al.
JOURNAL OF LIPID RESEARCH (2002)
Emerging roles of PPARs in inflammation and immunity
RA Daynes et al.
NATURE REVIEWS IMMUNOLOGY (2002)
Differential regulation of vascular endothelial growth factor expression by peroxisome proliferator-activated receptors in bladder cancer cells
S Fauconnet et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
C/EBP alpha induces adipogenesis through PPAR gamma: a unified pathway
ED Rosen et al.
GENES & DEVELOPMENT (2002)
Frequency and significance of Pro12Ala and Pro115Gln polymorphism in gene for peroxisome proliferation-activated receptor-γ2 regarding metabolic parameters in a Caucasian cohort
A Schäffler et al.
ENDOCRINE (2001)
Nuclear receptor ligand-binding domains three-dimensional structures, molecular interactions and pharmacological implications
W Bourguet et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2000)
The nuclear receptor PPARγ and immunoregulation:: PPARγ mediates inhibition of helper T cell responses
RB Clark et al.
JOURNAL OF IMMUNOLOGY (2000)
Distribution of peroxisome proliferator-activated receptors (PPARs) in human skeletal muscle and adipose tissue: relation to insulin action
M Loviscach et al.
DIABETOLOGIA (2000)
Clinical efficacy of new thiazolidinediones and glinides in the treatment of type 2 diabetes mellitus
M Fuchtenbusch et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2000)
Share Paper
